Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study

Biological Psychiatry

Volumn 56, Issue 5, 2004, Pages 349-355

  Daumann, Jörg ^a   Fischermann, Thomas ^a   Heekeren, Karsten ^b   Thron, Armin ^b   Gouzoulis Mayfrank, Euphrosyne ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Ecstasy; fMRI; MDMA; neurotoxicity; parietal cortex; working memory

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CANNABIS; PSYCHOTROPIC AGENT;

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; MEASUREMENT; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY;

ADULT; AMPHETAMINE; CANNABIS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; OXYGEN; REACTION TIME; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS;

EID: 4444244024     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.06.011     Document Type: Article

References (33)

1. S. Bhattachary, J.H. Powell Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or "ecstasy": Evidence for cognitive impairment Psychol Med 31 2001 647 658
2. K.I. Bolla, U.D. McCann, G.A. Ricaurte Memory impairment in abstinent MDMA ("Ecstasy") users Neurology 51 1998 1532 1537
3. J. Brown, H.R. Kranzler, F.K. Del Boca Self-reports by alcohol and drug abuse inpatients: Factors affecting reliability and validity Br J Addict 87 1992 1013 1024
4. R. Cabeza, L. Nyberg Imaging cognition II: An empirical review of 275 PET and fMRI studies J Cogn Neurosci 12 2000 1 47
5. M. Carvalho, F. Carvalho, F. Remiao, M. de Lourdes Pereira, R. Pres-das-Neves, M. de Lourdes Bastos Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: Influence of ambient temperature Arch Toxicol 76 2002 166 172
6. L. Chang, O. Speck, E.N. Miller, J. Braun, J. Jovicich, C Koch Neural correlates of attention and working memory deficits in HIV patients Neurology 57 2001 101 107
7. M.I. Colado, J. Camarero, A.O. Mechan, V. Sanchez, B. Esteban, J.M Elliot A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurones in mouse brain Br J Pharmacol 134 2001 1711 1723
8. J. Daumann, B. Fimm, K. Willmes, A. Thron, E. Gouzoulis-Mayfrank Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: A functional magnetic resonance imaging (fMRI) study Brain Res Cogn Brain Res 16 2003 479 487
9. J. Daumann, R. Schnitker, J. Weidemann, K. Schnell, A. Thron, E. Gouzoulis-Mayfrank Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users Neuroreport 15 2003 1983 1987
10. R. de la Torre, M. Farre, J. Ortuno, M. Mas, R. Brenneisen, P.N Roset Non-linear pharmacoginetics of MDMA ('esctasy') in humans Br J Clin Pharmacol 49 2000 104 109
11. T. Ernst, L. Chang, J. Jovicich, N. Ames, S. Arnold Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology 59 2002 1343 1349
12. 15O]-positron emission tomography study J Clin Psychopharmacol 21 2001 66 71
13. E. Gouzoulis-Mayfrank, J. Daumann, F. Tuchtenhagen, S. Pelz, S. Becker, H.-J., et al Kunert Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users J Neurol Neurosurg Psychiatry 68 2000 719 725
14. E. Gouzoulis-Mayfrank, B. Thimm, M. Rezk, G. Hensen, J. Daumann Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users Prog Neuropsychopharmacol Biol Psychiatry 27 2003 819 827
15. E.R. Harrison, J. Haaga, T. Richards Self-reported drug use data: What do they reveal? Am J Drug Alcohol Abuse 19 1993 423 441
16. G. Hatzidimitriou, U.D. McCann, G.A. Ricaurte Altered serotonin innervation patterns in the forebrain of monkeys treated with ±3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery J Neurosci 19 1999 5096 5107
17. L.K. Jacobsen, W.E. Mencl, K.R. Pugh, P. Skudlarski, J.H. Krystal Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: Possible relationship to neurotoxic effects Psychopharmacology (Berl) 173 3-4 2004 383 390
18. U.D. McCann, V. Eligulashvili, G.A. Ricaurte 3,4- methylenedioxymethamphetamine (ecstasy)-induced serotonin neurotoxicity: Clinical studies Neuropsychobiology 42 2000 11 16
19. U.D. McCann, M. Mertl, V. Eligulashvili, G.A. Ricaurte Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) users: A controlled study Psychopharmacology (Berl) 143 1999 417 425
20. M.J. Morgan Memory deficits associated with recreational use of "ecstasy" (MDMA) Psychopharmacology (Berl) 141 1999 30 36
21. M.J. Morgan, L. McFie, L.H. Fleetwood, J.A. Robinson Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl) 159 2002 294 303
22. E. O'Ohea, N. Easton, J.R. Fry, A.R. Green, C.A. Marsden Protection against 3,4-methylenedioxymethamphetamine induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia J Neurochem 81 2002 686 695
23. A.C. Parrott Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity Pharmacol Biochem Behav 71 2002 837 844
24. H.G. Pope Jr, A.J. Gruber, J.I. Hudson, M.A. Huestis, D. Yurgelun-Todd Neuropsychological performance in long-term cannabis users Arch Gen Psychiatry 58 2001 909 915
25. L. Reneman, J. Booij, J. Lavalaye, K. de Bruin, J.B. Reitsma, B Gunning Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: A [123I]beta-CIT SPECT study-preliminary report. Psychopharmacology (Berl) 159 2002 335 340
26. L. Reneman, J. Lavalaye, B. Schmand, F.A. de Wolff, W. van den Brink, G.J den Heeten Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") Arch Gen Psychiatry 58 2001 901 906
27. J. Rodgers Cognitive performance amongst recreational users of "ecstasy " Psychopharmacology (Berl) 151 2001 19 24
28. J. Talairach, P. Tournoux Co-planar Stereotaxic Atlas of the Human Brain 1988 Thieme Stuttgart, Germany
29. R. Thomasius, K. Petersen, R. Buchert, B. Andresen, P. Zapletalova, L Wartberg Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users Psychopharamcology (Berl) 167 2003 85 96
30. N.D. Volkow, L. Chang, G.-J. Wang, J.S. Fowler, M. Leonido-Yee, D Franceschi Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am J Psychiatry 158 2001 377 382
31. M. Wareing, J.E. Fisk, P.N. Murphy Working memory deficits in current and previous users of MDMA ("ecstasy") Br J Psychol 91 2000 181 188
32. E. Weir Raves: A review of the culture, the drugs and the prevention of harm Can Med Assoc J 162 2000 1843 1848
33. K.K. Zakzanis, D.A. Young, N.F. Radkhoshnoud Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users Appl Neuropsychol 9 2002 84 91